Barron’s Picks And Pans: Alibaba, AllianceBernstein, Pfizer And More, , on October 11, 2020 at 10:30 pm

By High West Capital Partners
On October 11, 2020
Tags:

* This weekend’s Barron’s cover story discusses why the lagging industrials could be poised for a decade of outperformance. * Other featured articles discuss how American manufacturing can be reinvigorated and the coming wave of consolidation in investment management. * Also, the prospects for a theater operators, an overlooked asset manager, a Chinese tech giant and more.Cover story “How to Play the Next Industrial Revolution” by Al Root points out that industrial stocks such as Caterpillar Inc. (NYSE: CAT) have lagged behind the S&P 500 index for the past 10 years. See why Barron’s believes better times are ahead. Could the sector see a decade of outperformance?Matthew C. Klein’s “The American Dream: Bringing Factories Back to the U.S.” suggests that decades of offshoring have left the American economy vulnerable. Restoring the nation’s production prowess will be a long, hard slog, but it can be accomplished if companies such as Intel Corporation (NASDAQ: INTC), politicians and investors get behind the effort.In “Movie Chains Reel as Box Offices Bomb,” Liz Moyer discusses why, with the pandemic lingering, movie houses are reeling from delayed releases from the likes of Walt Disney Co (NYSE: DIS), theater shutdowns and scarce ticket buyers. Can AMC Entertainment Holdings Inc (NYSE: AMC) and other theater operators survive until 2021?Pfizer Inc. (NYSE: PFE) wants a judgment in favor of programs that would let it help cover Medicare patients’ copays for an expensive cardiovascular drug, according to “Pfizer Suit Could Be an ‘Earthquake’ for Drug Pricing” by Eleanor Laise. See what impact the ruling could have on drug prices and the likes of Regeneron Pharmaceuticals Inc (NYSE: REGN).In Andrew Bary’s “Why AllianceBernstein Stands Out,” Barron’s make a case that Alliancebernstein Holding LP (NYSE: AB) should be one the hottest plays in its industry. After all, this New York-based asset manager offers a growth story, and it has a nearly 9% yield. Find out why Barron’s believes it generates so little attention from investors.See Also: 4 Issues That Will Determine If The Market’s Next Big Move Is Up Or Down”Eaton Vance Deal Presages More Money-Manager M&A” by Leslie P. Norton discusses why, in the wake of the Morgan Stanley (NYSE: MS) acquisition of Eaton Vance Corp (NYSE: EV), a wave of consolidation is likely as firms increasingly come under pressure to cut fees, trim expenses and boost investment performance.Diagnostic giant Laboratory Corp. of America Holdings (NYSE: LN) now processes 200,000 coronavirus tests a day. So says Jack Hough’s “LabCorp Has Been Tested by Covid-19. But It’s Now on a Roll.” See how this North Carolina-based clinical laboratory network operator is preparing for whatever the new normal will be.In “Using Alibaba to Hedge a U.S. Stock Portfolio,” Steven M. Sears claims that China might be the best hedge for U.S. stocks. Find out how e-commerce and technology giant Alibaba Group Holding Ltd (NYSE: BABA), given its broad scope, could act in the role once occupied by fixed income when it was an effective offset to equity weakness.Lawrence C. Strauss’s “The Tech Sector’s Dividend Allure Is in Growth, Not Yield” says that the tech sector, unlike utilities or consumer staples, isn’t the first option for dividend investors. However, some believe that they have a lot of runway to grow those dividends. See whether that includes Cisco Systems, Inc. (NASDAQ: CSCO), Lam Research Corporation (NASDAQ: LRCX) and others.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Last Week’s Notable Insider Buys: Element Solutions, Selecta Biosciences And More * Benzinga’s Bulls And Bears Of The Week: AT&T, Apple, Tesla And More(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.,

Barron's Picks And Pans: Alibaba, AllianceBernstein, Pfizer And More* This weekend’s Barron’s cover story discusses why the lagging industrials could be poised for a decade of outperformance. * Other featured articles discuss how American manufacturing can be reinvigorated and the coming wave of consolidation in investment management. * Also, the prospects for a theater operators, an overlooked asset manager, a Chinese tech giant and more.Cover story “How to Play the Next Industrial Revolution” by Al Root points out that industrial stocks such as Caterpillar Inc. (NYSE: CAT) have lagged behind the S&P 500 index for the past 10 years. See why Barron’s believes better times are ahead. Could the sector see a decade of outperformance?Matthew C. Klein’s “The American Dream: Bringing Factories Back to the U.S.” suggests that decades of offshoring have left the American economy vulnerable. Restoring the nation’s production prowess will be a long, hard slog, but it can be accomplished if companies such as Intel Corporation (NASDAQ: INTC), politicians and investors get behind the effort.In “Movie Chains Reel as Box Offices Bomb,” Liz Moyer discusses why, with the pandemic lingering, movie houses are reeling from delayed releases from the likes of Walt Disney Co (NYSE: DIS), theater shutdowns and scarce ticket buyers. Can AMC Entertainment Holdings Inc (NYSE: AMC) and other theater operators survive until 2021?Pfizer Inc. (NYSE: PFE) wants a judgment in favor of programs that would let it help cover Medicare patients’ copays for an expensive cardiovascular drug, according to “Pfizer Suit Could Be an ‘Earthquake’ for Drug Pricing” by Eleanor Laise. See what impact the ruling could have on drug prices and the likes of Regeneron Pharmaceuticals Inc (NYSE: REGN).In Andrew Bary’s “Why AllianceBernstein Stands Out,” Barron’s make a case that Alliancebernstein Holding LP (NYSE: AB) should be one the hottest plays in its industry. After all, this New York-based asset manager offers a growth story, and it has a nearly 9% yield. Find out why Barron’s believes it generates so little attention from investors.See Also: 4 Issues That Will Determine If The Market’s Next Big Move Is Up Or Down”Eaton Vance Deal Presages More Money-Manager M&A” by Leslie P. Norton discusses why, in the wake of the Morgan Stanley (NYSE: MS) acquisition of Eaton Vance Corp (NYSE: EV), a wave of consolidation is likely as firms increasingly come under pressure to cut fees, trim expenses and boost investment performance.Diagnostic giant Laboratory Corp. of America Holdings (NYSE: LN) now processes 200,000 coronavirus tests a day. So says Jack Hough’s “LabCorp Has Been Tested by Covid-19. But It’s Now on a Roll.” See how this North Carolina-based clinical laboratory network operator is preparing for whatever the new normal will be.In “Using Alibaba to Hedge a U.S. Stock Portfolio,” Steven M. Sears claims that China might be the best hedge for U.S. stocks. Find out how e-commerce and technology giant Alibaba Group Holding Ltd (NYSE: BABA), given its broad scope, could act in the role once occupied by fixed income when it was an effective offset to equity weakness.Lawrence C. Strauss’s “The Tech Sector’s Dividend Allure Is in Growth, Not Yield” says that the tech sector, unlike utilities or consumer staples, isn’t the first option for dividend investors. However, some believe that they have a lot of runway to grow those dividends. See whether that includes Cisco Systems, Inc. (NASDAQ: CSCO), Lam Research Corporation (NASDAQ: LRCX) and others.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Last Week’s Notable Insider Buys: Element Solutions, Selecta Biosciences And More * Benzinga’s Bulls And Bears Of The Week: AT&T, Apple, Tesla And More(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

,

Instant Quote

Enter the Stock Symbol.

Select the Exchange.

Select the Type of Security.

Please enter your First Name.

Please enter your Last Name.

Please enter your phone number.

Please enter your Email Address.

Please enter or select the Total Number of Shares you own.

Please enter or select the Desired Loan Amount you are seeking.

Please select the Loan Purpose.

Please select if you are an Officer/Director.

High West Capital Partners, LLC may only offer certain information to persons who are “Accredited Investors” and/or “Qualified Clients” as those terms are defined under applicable Federal Securities Laws. In order to be an “Accredited Investor” and/or a “Qualified Client”, you must meet the criteria identified in ONE OR MORE of the following categories/paragraphs numbered 1-20 below.

High West Capital Partners, LLC cannot provide you with any information regarding its Loan Programs or Investment Products unless you meet one or more of the following criteria. Furthermore, Foreign nationals who may be exempt from qualifying as a U.S. Accredited Investor are still required to meet the established criteria, in accordance with High West Capital Partners, LLC’s internal lending policies. High West Capital Partners, LLC will not provide information or lend to any individual and/or entity that does not meet one or more of the following criteria:

1) Individual with Net Worth in excess of $1.0 million. A natural person (not an entity) whose net worth, or joint net worth with his or her spouse, at the time of purchase exceeds $1,000,000 USD. (In calculating net worth, you may include your equity in personal property and real estate, including your principal residence, cash, short-term investments, stock and securities. Your inclusion of equity in personal property and real estate should be based on the fair market value of such property less debt secured by such property.)

2) Individual with $200,000 individual Annual Income. A natural person (not an entity) who had individual income of more than $200,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

3) Individual with $300,000 Joint Annual Income. A natural person (not an entity) who had joint income with his or her spouse in excess of $300,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

4) Corporations or Partnerships. A corporation, partnership, or similar entity that has in excess of $5 million of assets and was not formed for the specific purpose of acquiring an interest in the Corporation or Partnership.

5) Revocable Trust. A trust that is revocable by its grantors and each of whose grantors is an Accredited Investor as defined in one or more of the other categories/paragraphs numbered herein.

6) Irrevocable Trust. A trust (other than an ERISA plan) that (a)is not revocable by its grantors, (b) has in excess of $5 million of assets, (c) was not formed for the specific purpose of acquiring an interest, and (d) is directed by a person who has such knowledge and experience in financial and business matters that such person is capable of evaluating the merits and risks of an investment in the Trust.

7) IRA or Similar Benefit Plan. An IRA, Keogh or similar benefit plan that covers only a single natural person who is an Accredited Investor, as defined in one or more of the other categories/paragraphs numbered herein.

8) Participant-Directed Employee Benefit Plan Account. A participant-directed employee benefit plan investing at the direction of, and for the account of, a participant who is an Accredited Investor, as that term is defined in one or more of the other categories/paragraphs numbered herein.

9) Other ERISA Plan. An employee benefit plan within the meaning of Title I of the ERISA Act other than a participant-directed plan with total assets in excess of $5 million or for which investment decisions (including the decision to purchase an interest) are made by a bank, registered investment adviser, savings and loan association, or insurance company.

10) Government Benefit Plan. A plan established and maintained by a state, municipality, or any agency of a state or municipality, for the benefit of its employees, with total assets in excess of $5 million.

11) Non-Profit Entity. An organization described in Section 501(c)(3) of the Internal Revenue Code, as amended, with total assets in excess of $5 million (including endowment, annuity and life income funds), as shown by the organization’s most recent audited financial statements.

12) A bank, as defined in Section 3(a)(2) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

13) A savings and loan association or similar institution, as defined in Section 3(a)(5)(A) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

14) A broker-dealer registered under the Exchange Act.

15) An insurance company, as defined in Section 2(13) of the Securities Act.

16) A “business development company,” as defined in Section 2(a)(48) of the Investment Company Act.

17) A small business investment company licensed under Section 301 (c) or (d) of the Small Business Investment Act of 1958.

18) A “private business development company” as defined in Section 202(a)(22) of the Advisers Act.

19) Executive Officer or Director. A natural person who is an executive officer, director or general partner of the Partnership or the General Partner, and is an Accredited Investor as that term is defined in one or more of the categories/paragraphs numbered herein.

20) Entity Owned Entirely By Accredited Investors. A corporation, partnership, private investment company or similar entity each of whose equity owners is a natural person who is an Accredited Investor, as that term is defined in one or more of the categories/paragraphs numbered herein.

Please read the notice above and check the box below to continue.

Singapore

168 Robinson Road,
Capital Tower, Singapore 068912
+65 3105 1295

Taiwan

5th Floor, No. 1-8, Section 5, Zhongxiao East Road, Taipei

Hong Kong

R91, 3rd Floor,
Eton Tower, 8 Hysan Ave.
Causeway Bay, Hong Kong
+852 3002 4462

Australia

44 Martin Place, Sydney 2000 Australia
+02 8319 3232

Indonesia

Millennium Centennial Center, 38th Floor, Jl. Jend. Sudirman Kav. 25
Jakarta 12920, Indonesia

Market Coverage